| Home | E-Submission | Sitemap | Contact Us |  
Korean Journal of Clinical Oncology > Article
Korean J Clin Oncol. 2010;6(1): 47-53.         doi: https://doi.org/10.14216/kjco.10007
The impact of the serum CEA on pathological tumor response after preoperative chemoradiotherapy with total mesorectal excision for rectal cancer
HongJin Shim1, Jeonghyun Kang1, Young Wan Kim2, Hyung Soon Lee1, Hyuk Hur1, Byung Soh Min1, Kang Young Lee1, Nam Kyu Kim1
1Department of Surgery Yonsei University Health System, Yonsei University College of Medicine, Seoul, South Korea
2Department of Surgery Bucheon Hospital, Suncheonhyang university College of Medicine, Seoul, South Korea
수술전 화학방사선 요법을 시행 받은 직장암에서 혈중 암종배아항원과 조직학적 치료반응도와의 상관관계분석
심홍진1, 강정현1, 김영완2, 이형순1, 허혁1, 민병소1, 이강영1, 김남규1
1연세대학교 의과대학 외과학교실
2순천향대학교 부천병원 외과학교실
Corresponding Author: Nam Kyu Kim ,Tel: +82-2-2228-2117, Fax: +82-2-313-8289, Email: namkyuk@yuhs.ac
Received: May 20, 2010;  Accepted: June 23, 2010.
Share :  
Purpose: This study was designed to assess whether serum CEA is associated with pathological tumor response in rectal cancer patients who underwent preoperative chemoradiation therapy (CRT) with total mesorectal excision (TME).
Methods: Eighty-five patients with rectal cancer who were treated by preoperative CRT followed by TME were enrolled between August 2005 and December 2007. 5-FU based chemotherapy and 5040 cGy of radiation were delivered. Serum CEA was measured pre-CRT, post-CRT, and post-TME period. Among 85 patients, 29 patients did not have post-CRT CEA level. Pathological tumor response (ypTNM stage) was categorized into two groups as follows; favorable response group (group A: n=28, pathological complete response and ypTNM I) vs unfavorable response group (group B: n=57, ypTNM II and III). Median follow-up period was 29.2 months (range 1.1-50.2 months).
Results: There were no differences between favorable and unfavorable response group with respect to age, gender, tumor location, lymphovascular invasion, and perineural invasion (Table 1). Anal sphincter preservation surgery was more commonly performed in the group A when compared with group B (26 (92.9%) vs. 41 (71.9%)) (p=0.026). Well and moderately differentiated histology were more commonly found in the group A (26(92.9%) vs. 40(70.2%) (p=0.018). Low level of pre-CRT CEA (<5ng/ml) was more commonly found in the group A (26(92.9%) vs. 30 (52.6%) (p=0.000). However, there was no difference between group A and B with regard to post-CRT CEA and post-TME CEA. Logistic regression analyses showed that pre-CRT CEA (<5ng/ml) and sphincter preservation surgery were associated with favorable pathological tumor response.
Conclusions: Low level of pre-CRT CEA (<5ng/ml) is predictive of favorable pathological tumor response but serum level of post-CRT and post-TME CEA did not have significant association with tumor response. This result should be validated in larger prospective randomized study near future.
Keywords: Preoperative chemoradiation | rectal cancer | CEA | pathologic response
Editorial Office
101-3304 Brownstone Seoul, 464 Cheongpa-ro, Jung-gu, Seoul 04510, Korea
TEL : +82-2-393-2114   FAX : +82-2-393-1649   E-mail : office@kjco.org

Copyright© Korean Society of Surgical Oncology.                Developed in M2PI
About |  Browse Articles |  Current Issue |  For Authors and Reviewers